Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Altamira Therapeutics Business Update and Full Year 2023 Earnings Conference Call.
Altamira Therapeutics Ltd. (CYTO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,814 | $23,713 | 0% | |
| 2. | 851 | $2,961 | 0% | |
| 3. | 14 | $49 | 0% | |
| 4. | 1 | $3 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Altamira Therapeutics First Half 2023 Financial Results and Business Update Conference Call.
Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Altamira Therapeutics 2022 Results Conference Call.
5 Stocks Targeted By Short Sellers Recently
Altamira Therapeutics Ltd. (NASDAQ:CYTO) is a biotechnology company that is headquartered in Hamilton, Bermuda.